Aurora Cannabis (ACB) Income from Non-Controlling Interests (2018 - 2025)
Aurora Cannabis (ACB) reported Income from Non-Controlling Interests of $22.6 million for Q4 2025, up 9768.83% year-over-year from $228637.4 in Q4 2024, and down 11.76% quarter-over-quarter from $25.6 million in Q3 2025.
Aurora Cannabis (ACB) Income from Non-Controlling Interests (2018 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 8 years of Income from Non-Controlling Interests data on file, last reported at $22.6 million in Q4 2025.
- Income from Non-Controlling Interests for Q4 2025 came in at $22.6 million, up 9768.83% year-over-year; the trailing twelve-month figure through Dec 2025 was $22.6 million (up 1468.42% YoY), and the FY2025 annual result was $28.9 million, up 1138.93% from the prior year.
- Income from Non-Controlling Interests fell to $22.6 million in Q4 2025 per ACB's latest filing, from $25.6 million in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $30.7 million in Q4 2023 and troughed at -$1.3 million in Q4 2022.
- A 5-year average of $8.8 million and a median of $264934.4 in 2024 frame the typical range for Income from Non-Controlling Interests.
- On a YoY basis, Income from Non-Controlling Interests climbed as much as 1455025.06% in 2023 and fell as far as 451.4% in 2023.
- A 5-year view of Income from Non-Controlling Interests shows it stood at $395081.4 in 2021, then slumped by 433.97% to -$1.3 million in 2022, then jumped by 2423.69% to $30.7 million in 2023, then plunged by 100.76% to -$233366.8 in 2024, then soared by 9768.83% to $22.6 million in 2025.
- Business Quant data shows ACB's Income from Non-Controlling Interests at $22.6 million in Q4 2025, $25.6 million in Q3 2025, and $26.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 22.56 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.56 Mn |
| Sep 30, 2025 | 25.57 Mn |
| Jun 30, 2025 | 26.53 Mn |
| Mar 31, 2025 | 1.36 Mn |
| Dec 31, 2024 | -233,366.82 |
| Sep 30, 2024 | -677,341.35 |
| Jun 30, 2024 | -1.00 Mn |
| Mar 31, 2024 | 264,934.42 |
| Dec 31, 2023 | 30.66 Mn |
| Sep 30, 2023 | -1.20 Mn |
| Jun 30, 2023 | 23.97 Mn |
| Mar 31, 2023 | 22.98 Mn |
| Dec 31, 2022 | -1.32 Mn |
| Sep 30, 2022 | -216,989.19 |
| Jun 30, 2022 | 8,627.75 |
| Mar 31, 2022 | 1,578.95 |
| Dec 31, 2021 | 395,081.37 |
| Sep 30, 2020 | -1.10 Mn |
| Jun 30, 2020 | -17.57 Mn |
| Mar 31, 2020 | -14.78 Mn |